Trimodulin

BT588 · Biotest AG

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Trimodulin, covering 2023-01-10 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) [Phase 3]